{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:03:58Z","timestamp":1780495438683,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-04840-7","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:05:30Z","timestamp":1776776730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pars planitis: a study of clinical features and treatment results"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4878-824X","authenticated-orcid":false,"given":"Mehtap","family":"Caglayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5535-264X","authenticated-orcid":false,"given":"Dilbade Yildiz","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"4840_CR1","first-page":"16972","volume-title":"Uveitis Update","author":"HJ Kaplan","year":"1984","unstructured":"Kaplan HJ. Intermediate uveitis (pars planitis, chronic cyclitis) \u2013 A four step approach to treatment. In: Saari KM, editor. Uveitis Update. Amsterdam: Experta Medica; 1984. p. 16972."},{"key":"4840_CR2","first-page":"46980","volume":"10","author":"P Cakar Ozdal","year":"2015","unstructured":"Cakar Ozdal P, Berker N, Tugal Tutkun \u0130. Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis. J Ophthalmic Vis Res. 2015;10:46980.","journal-title":"J Ophthalmic Vis Res"},{"key":"4840_CR3","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00417-015-3124-x","volume":"253","author":"R Sella","year":"2015","unstructured":"Sella R, Oray M, Friling R, Umar L, Tugal-Tutkun I, Kramer M. Dexamethasone intravitreal implant (Ozurdex\u00ae) for pediatric uveitis. Graefes Arch Clin Exp Ophthalmol. 2015;253:1777\u201382.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4840_CR4","doi-asserted-by":"publisher","first-page":"8449","DOI":"10.1016\/j.ajo.2007.08.018","volume":"144","author":"SP Ardoin","year":"2007","unstructured":"Ardoin SP, Kredich D, Rabinovich E, Schanberg LE, Jaffe GJ. Infliximab to treat chronic noninfectious uveitis in children: Retrospective case series with long term follow up. Am J Ophthalmol. 2007;144:8449.","journal-title":"Am J Ophthalmol"},{"key":"4840_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00417-021-05398-4","volume":"260","author":"HB Ozdemir","year":"2022","unstructured":"Ozdemir HB, Ozdal PC. Clinical characteristics and treatment of pars planitis: an adalimumab experience. Graefes Arch Clin Exp Ophthalmol. 2022;260:561\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4840_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ajo.2021.03.045","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","unstructured":"Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for pars planitis. Am J Ophthalmol. 2021;228:268\u201374.","journal-title":"Am J Ophthalmol"},{"key":"4840_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10792-008-9263-x","volume":"30","author":"I Tugal-Tutkun","year":"2010","unstructured":"Tugal-Tutkun I, Herbort CP, Khairallah M, The Angiography Scoring for Uveitis Working Group (ASUWOG). Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol. 2010;30:539\u201352.","journal-title":"Int Ophthalmol"},{"key":"4840_CR8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ajo.2007.08.023","volume":"144","author":"MJ Donaldson","year":"2007","unstructured":"Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D. Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol. 2007;144:812\u20137.","journal-title":"Am J Ophthalmol"},{"key":"4840_CR9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1046\/j.1442-9071.2001.d01-7.x","volume":"29","author":"S Guest","year":"2001","unstructured":"Guest S, Funkhouser E, Lightman S. Pars planitis: A comparison of childhood onset and adult onset disease. Clin Exp Ophthalmol. 2001;29:814.","journal-title":"Clin Exp Ophthalmol"},{"key":"4840_CR10","first-page":"24954","volume":"6","author":"H Nikkhah","year":"2011","unstructured":"Nikkhah H, Ramezani A, Ahmadieh H, Soheilian M, Azarmina M, Dehghan MH, et al. Childhood pars planitis; clinical features and outcomes. J Ophthalmic Vis Res. 2011;6:24954.","journal-title":"J Ophthalmic Vis Res"},{"key":"4840_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12348-011-0044-8","volume":"2","author":"PC Ozdal","year":"2012","unstructured":"Ozdal PC, Sen E, Yazici A, Ozturk F. Patterns of childhood-onset uveitis in a referral center in Turkey. J Ophthalmic Inflamm Infect. 2012;2:13\u20139.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"4","key":"4840_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1080\/09273948.2024.2421386","volume":"33","author":"A Y\u0131lmaz \u00c7ebi","year":"2025","unstructured":"Y\u0131lmaz \u00c7ebi A, K\u0131l\u0131\u00e7arslan O, U\u00e7ar D. Long-Term Outcomes of Pediatric Pars Planitis: Retrospective Cohort from a Single Tertiary Center in Turkey. Ocul Immunol Inflamm. 2025;33(4):556\u201360. https:\/\/doi.org\/10.1080\/09273948.2024.2421386.","journal-title":"Ocul Immunol Inflamm"},{"key":"4840_CR13","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.ophtha.2004.06.014","volume":"111","author":"KD Rosenberg","year":"2004","unstructured":"Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111:2299\u2013306.","journal-title":"Ophthalmology"},{"key":"4840_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0161-6420(93)31567-8","volume":"100","author":"SM Malinowski","year":"1993","unstructured":"Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology. 1993;100:818\u201324. discussion 825.","journal-title":"Ophthalmology"},{"key":"4840_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12886-020-01373-5","volume":"20","author":"S Ozates","year":"2020","unstructured":"Ozates S, Berker N, Ozdal PC, Ozdamar Erol Y. Phacoemulsification in patients with uveitis: long-term outcomes. BMC Ophthalmol. 2020;20:109.","journal-title":"BMC Ophthalmol"},{"key":"4840_CR16","volume-title":"Pars planitis. Posterior Segment Intraocular Inflammation: Guidelines","author":"JV Forrester","year":"1998","unstructured":"Forrester JV, Okada AA, Ben Ezra D, et al. Pars planitis. Posterior Segment Intraocular Inflammation: Guidelines. The Hague, Netherlands: Kugler; 1998. 93 7."},{"key":"4840_CR17","first-page":"1223","volume-title":"Diagnosis and Treatment of Uveitis","author":"L Kump","year":"2013","unstructured":"Kump L, Vitale AT, Foster CS. Pediatric uveitis. In: Foster C, Vitale A, editors. Diagnosis and Treatment of Uveitis. New Delhi, India: Highlights Medical; 2013. pp. 1223\u20135."},{"key":"4840_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","volume":"33","author":"AL Buchman","year":"2001","unstructured":"Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33:289\u201394.","journal-title":"J Clin Gastroenterol"},{"key":"4840_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2017-212089","volume":"77","author":"P Quartier","year":"2018","unstructured":"Quartier P, Baptiste A, Despert V, Allain-Launay E, Kon\u00e9-Paut I, Belot A, et al. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Ann Rheum Dis. 2018;77:1003\u201311.","journal-title":"Ann Rheum Dis"},{"key":"4840_CR20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, Kumar Kurup S, Sheppard J, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebocontrolled phase 3 trial. Lancet. 2016;388:1183\u201392.","journal-title":"Lancet"},{"key":"4840_CR21","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","volume":"125","author":"EB Suhler","year":"2018","unstructured":"Suhler EB, Adan A, Brezin AP, Fortin E, Goto H, Jaffe GJ, et al. Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III. Ophthalmology. 2018;125:1075\u201387.","journal-title":"Ophthalmology"},{"issue":"1","key":"4840_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10792-022-02398-z","volume":"43","author":"MD Ozer","year":"2023","unstructured":"Ozer MD, Batur M. Anti-tumor necrosis factor-alpha treatment in pediatric patients with pars planitis: a single-center experience from Turkey. Int Ophthalmol. 2023;43(1):155\u201366. https:\/\/doi.org\/10.1007\/s10792-022-02398-z.","journal-title":"Int Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04840-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:03:13Z","timestamp":1780491793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04840-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4840"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04840-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of Gazi Yasargil Training and Research Hospital (2024\/132). The study adhered to the tenets of the Declaration of Helsinki. As all participants were under the age of 18, written informed consent was obtained from their parents or legal guardians prior to inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}